U.S. Senate committee chair: Mylan's response on EpiPen price hike 'incomplete'

WASHINGTON, Sept 9 (Reuters) - The chairman of the U.S.
Senate Judiciary Committee probing Mylan NV's EpiPen
price hike on Friday said its response to his query was
"incomplete," and called on the...